JP2003534013A - 哺乳動物レセプタータンパク質；関連試薬および方法 - Google Patents

哺乳動物レセプタータンパク質；関連試薬および方法

Info

Publication number
JP2003534013A
JP2003534013A JP2001587152A JP2001587152A JP2003534013A JP 2003534013 A JP2003534013 A JP 2003534013A JP 2001587152 A JP2001587152 A JP 2001587152A JP 2001587152 A JP2001587152 A JP 2001587152A JP 2003534013 A JP2003534013 A JP 2003534013A
Authority
JP
Japan
Prior art keywords
dcrs8
polypeptide
dcrs9
sequence
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001587152A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003534013A5 (enExample
Inventor
ダニエル エム． ゴーマン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of JP2003534013A publication Critical patent/JP2003534013A/ja
Publication of JP2003534013A5 publication Critical patent/JP2003534013A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2001587152A 2000-05-24 2001-05-23 哺乳動物レセプタータンパク質；関連試薬および方法 Pending JP2003534013A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20686200P 2000-05-24 2000-05-24
US60/206,862 2000-05-24
PCT/US2001/016767 WO2001090358A2 (en) 2000-05-24 2001-05-23 Mammalian receptor proteins; related reagents and methods

Publications (2)

Publication Number Publication Date
JP2003534013A true JP2003534013A (ja) 2003-11-18
JP2003534013A5 JP2003534013A5 (enExample) 2008-07-10

Family

ID=22768279

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001587152A Pending JP2003534013A (ja) 2000-05-24 2001-05-23 哺乳動物レセプタータンパク質；関連試薬および方法

Country Status (8)

Country Link
US (2) US20030092881A1 (enExample)
EP (1) EP1303604A2 (enExample)
JP (1) JP2003534013A (enExample)
CN (1) CN1444652A (enExample)
AU (1) AU2001274920A1 (enExample)
CA (1) CA2410083A1 (enExample)
MX (1) MXPA02011617A (enExample)
WO (1) WO2001090358A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016510342A (ja) * 2013-02-15 2016-04-07 トーマス・ジェファーソン・ユニバーシティＴｈｏｍａｓ Ｊｅｆｆｅｒｓｏｎ Ｕｎｉｖｅｒｓｉｔｙ 腫瘍画像化のためのキット

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
CA2328496C (en) 1998-05-15 2016-01-05 Genentech, Inc. Il-17 homologous polypeptides and therapeutic uses thereof
US20040043397A1 (en) 2000-01-11 2004-03-04 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
DK1897944T3 (da) * 1999-12-23 2011-10-24 Genentech Inc IL-17 homologe polypeptider og terapeutisk anvendelse deraf
US7094566B2 (en) 2000-03-16 2006-08-22 Amgen Inc., IL-17 receptor like molecules and uses thereof
AR028256A1 (es) * 2000-03-16 2003-04-30 Amgen Inc Moleculas similares a receptores il-17 y usos de las mismas
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
US20040197306A1 (en) * 2000-05-24 2004-10-07 Gorman Daniel M. Mammalian receptor proteins; related reagents and methods
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2002004519A2 (en) * 2000-07-06 2002-01-17 Zymogenetics, Inc. Murine cytokine receptor
EP1529843A3 (en) * 2000-08-11 2005-06-08 Eli Lilly & Company Novel secreted proteins and their uses
WO2002038764A2 (en) * 2000-11-10 2002-05-16 The Regents Of The University Of California Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage
EP2383278A1 (en) * 2002-07-08 2011-11-02 Genentech, Inc. Method to determine B cell mediated diseases
US20060281146A1 (en) * 2002-09-11 2006-12-14 Genetech, Inc. Novel compositions and methods for the treatment of immune related diseases
AU2004259638C1 (en) 2003-07-08 2018-12-20 Novartis Pharma Ag IL-17 A/F heterologous polypeptides and therapeutic uses thereof
BRPI0511952A (pt) * 2004-06-10 2008-01-29 Zymogenetics Inc receptor solúvel isolado, anticorpo ou fragmento de anticorpo, e, métodos de reduzir inflamação induzida por il-17a ou induzida por il-17f, de tratar um mamìfero afetado com uma doença inflamatória, e uma condição patológica em um indivìduo associada com atividade de zcytor14
US20060142192A1 (en) * 2004-10-18 2006-06-29 Zeren Gao Soluble ZcytoR21, anti-ZcytoR21 antibodies and binding partners and methods of using in inflammation
US20060147945A1 (en) * 2005-01-06 2006-07-06 Edmonds Brian T Novel secreted proteins and their uses
US20070249533A1 (en) 2005-09-28 2007-10-25 Levin Steven D Il-17a and il-17f antagonists and methods of using the same
DK1931697T3 (da) * 2005-09-28 2010-11-08 Zymogenetics Inc IL-17A og IL-17F-antagonister og fremgangsmåder til anvendelse af disse
US7622116B2 (en) * 2006-02-10 2009-11-24 Zymogenetics, Inc. Method of treating inflammation using soluble IL-17RCX4
US7790676B2 (en) 2007-03-28 2010-09-07 Zymogenetics, Inc. Soluble IL-17RA/RC fusion proteins
SG10201608871XA (en) 2008-05-05 2016-12-29 Novimmune Sa Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
CA2759848C (en) 2009-05-05 2018-12-04 Novimmune S.A. Anti-il-17f antibodies and methods of use thereof
US9611295B2 (en) * 2011-10-27 2017-04-04 The Cleveland Clinic Foundation Treatment of IL-17 mediated disease by blocking SEFIR-SEFIR interactions
CN106794194A (zh) * 2014-06-30 2017-05-31 中央研究院 用于癌症治疗的介白素‑17受体b（il‑17rb）及其配体il‑17b之拮抗剂
EP4193154A4 (en) * 2020-08-07 2024-10-02 Athos Therapeutics, Inc. EX VIVO GASTROINTESTINAL BIOPSY PLATFORM FOR EVALUATION OF MULTI-OMICS SIGNATURES FOR SCREENING OF CANDIDATE THERAPEUTIC PRODUCTS

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999055865A1 (en) * 1998-04-29 1999-11-04 Genesis Research And Development Corporation Limited Polynucleotides isolated from skin cells and methods for their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ306653A (en) * 1995-03-23 1999-03-29 Immunex Corp Isolated dna il-17 receptors
US6635443B1 (en) * 1997-09-17 2003-10-21 Human Genome Sciences, Inc. Polynucleotides encoding a novel interleukin receptor termed interleukin-17 receptor-like protein
US6150502A (en) * 1998-04-29 2000-11-21 Genesis Research & Development Corporation Limited Polypeptides expressed in skin cells
ATE444361T1 (de) * 1999-12-23 2009-10-15 Genentech Inc Il-17 und il-17r homologe polypeptide und deren therapeutische verwendungen
AR028256A1 (es) * 2000-03-16 2003-04-30 Amgen Inc Moleculas similares a receptores il-17 y usos de las mismas
US20040197306A1 (en) * 2000-05-24 2004-10-07 Gorman Daniel M. Mammalian receptor proteins; related reagents and methods

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999055865A1 (en) * 1998-04-29 1999-11-04 Genesis Research And Development Corporation Limited Polynucleotides isolated from skin cells and methods for their use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016510342A (ja) * 2013-02-15 2016-04-07 トーマス・ジェファーソン・ユニバーシティＴｈｏｍａｓ Ｊｅｆｆｅｒｓｏｎ Ｕｎｉｖｅｒｓｉｔｙ 腫瘍画像化のためのキット

Also Published As

Publication number Publication date
EP1303604A2 (en) 2003-04-23
CN1444652A (zh) 2003-09-24
WO2001090358A3 (en) 2003-01-23
AU2001274920A1 (en) 2001-12-03
US20030092881A1 (en) 2003-05-15
US20050009145A1 (en) 2005-01-13
WO2001090358A2 (en) 2001-11-29
MXPA02011617A (es) 2003-03-10
CA2410083A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
JP2003534013A (ja) 哺乳動物レセプタータンパク質；関連試薬および方法
EP1798288B1 (en) Human Toll-like receptor proteins, related reagents and methods
JP5073909B2 (ja) 哺乳動物レセプタータンパク質；関連する試薬および方法
US20080025974A1 (en) Human Receptor Proteins; Related Reagents and Methods
JP2007269802A (ja) 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2012072186A (ja) Ｏｘ２レセプターホモログ
WO1999040195A1 (en) Mammalian receptor proteins; related reagents and methods
JP2003523179A (ja) 哺乳動物レセプタータンパク質；関連する試薬および方法
KR20030003761A (ko) 사람 수용체 단백질, 관련 시약 및 방법
JP2002505879A (ja) ヒトレセプタータンパク質；関連する試薬および方法
US20030082734A1 (en) Mammalian receptor proteins; related reagents and methods
AU2008203172B2 (en) OX2 receptor homologs
MXPA00003774A (en) Human receptor proteins;related reagents and methods
MXPA00008848A (en) Human receptor proteins;related reagents and methods
HK1102720B (en) Human toll-like receptor proteins, related reagents and methods
HK1159169A (en) Ox2 receptor homolog
HK1022175B (en) Human toll-like receptor proteins, related reagents and methods
HK1120291A (en) Human toll-like receptor proteins, related reagents and methods

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080512

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080512

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110217

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110915